pleuropulmonary blastoma
Conditions
Interventions
Case series:Nil
Sponsors
National Center for Children's Health; Capital Medical University, Beijing Children's Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: This study plans to recruit patients from various children's cancer centers in China. Those who meet one of the following conditions will be registered. Eligible diagnoses include SUSPECTED OR CONFIRMED: 1) Pleuropulmonary blastoma (PPB); 2) varian Sertoli-Leydig cell tumor or gynandroblastoma; 3) Gynandroblastoma; 4) Renal sarcoma; 5) Pulmonary sarcoma; 6) Embryonal rhabdomyosarcoma of the female genitourinary tract (ovary, fallopian tube, uterus); 7) Any other cancer documented by genetic testing to be DICER1-related; Prior therapy: There are no prior therapy restrictions; Be able to provide informed consent.
Exclusion criteria
Exclusion criteria: Patients who may not be able to comply with the protocol, who are unable to cooperate or patients who are believed that other conditions are not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;Disease free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| best overall response to chemotherapy; | — |
Countries
China
Contacts
Public ContactXiaoli Ma, Qi Zeng
National Center for Children's Health; Capital Medical University, Beijing Children's Hospital
Outcome results
None listed